BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29053787)

  • 1. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice.
    Devoy A; Kalmar B; Stewart M; Park H; Burke B; Noy SJ; Redhead Y; Humphrey J; Lo K; Jaeger J; Mejia Maza A; Sivakumar P; Bertolin C; Soraru G; Plagnol V; Greensmith L; Acevedo Arozena A; Isaacs AM; Davies B; Fratta P; Fisher EMC
    Brain; 2017 Nov; 140(11):2797-2805. PubMed ID: 29053787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function.
    Sharma A; Lyashchenko AK; Lu L; Nasrabady SE; Elmaleh M; Mendelsohn M; Nemes A; Tapia JC; Mentis GZ; Shneider NA
    Nat Commun; 2016 Feb; 7():10465. PubMed ID: 26842965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
    Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
    Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
    Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
    Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
    Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
    Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis.
    Picchiarelli G; Demestre M; Zuko A; Been M; Higelin J; Dieterlé S; Goy MA; Mallik M; Sellier C; Scekic-Zahirovic J; Zhang L; Rosenbohm A; Sijlmans C; Aly A; Mersmann S; Sanjuan-Ruiz I; Hübers A; Messaddeq N; Wagner M; van Bakel N; Boutillier AL; Ludolph A; Lagier-Tourenne C; Boeckers TM; Dupuis L; Storkebaum E
    Nat Neurosci; 2019 Nov; 22(11):1793-1805. PubMed ID: 31591561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model.
    Zhang X; Wang F; Hu Y; Chen R; Meng D; Guo L; Lv H; Guan J; Jia Y
    Brain; 2020 May; 143(5):1350-1367. PubMed ID: 32358598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
    Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
    Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
    Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
    Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model.
    Crivello M; Hogg MC; Jirström E; Halang L; Woods I; Rayner M; Coughlan KS; Lewandowski SA; Prehn JHM
    Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31383794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS.
    Bourefis AR; Campanari ML; Buee-Scherrer V; Kabashi E
    Neurobiol Dis; 2020 Aug; 142():104935. PubMed ID: 32380281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS.
    Vazquez-Sanchez S; Tilkin B; Gasset-Rosa F; Zhang S; Piol D; McAlonis-Downes M; Artates J; Govea-Perez N; Verresen Y; Guo L; Cleveland DW; Shorter J; Da Cruz S
    Mol Neurodegener; 2024 Jun; 19(1):46. PubMed ID: 38862967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha.
    Kia A; McAvoy K; Krishnamurthy K; Trotti D; Pasinelli P
    Glia; 2018 May; 66(5):1016-1033. PubMed ID: 29380416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice.
    So E; Mitchell JC; Memmi C; Chennell G; Vizcay-Barrena G; Allison L; Shaw CE; Vance C
    Hum Mol Genet; 2018 Feb; 27(3):463-474. PubMed ID: 29194538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS.
    Shahidullah M; Le Marchand SJ; Fei H; Zhang J; Pandey UB; Dalva MB; Pasinelli P; Levitan IB
    J Neurosci; 2013 Dec; 33(50):19590-8. PubMed ID: 24336723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis.
    Korobeynikov VA; Lyashchenko AK; Blanco-Redondo B; Jafar-Nejad P; Shneider NA
    Nat Med; 2022 Jan; 28(1):104-116. PubMed ID: 35075293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.